The differentiation inducers phenylacetate and phenylbutyrate modulate camptothecin sensitivity in colon carcinoma cells in vitro by intracellular acidification
E. Cosentini et al., The differentiation inducers phenylacetate and phenylbutyrate modulate camptothecin sensitivity in colon carcinoma cells in vitro by intracellular acidification, INT J ONCOL, 19(5), 2001, pp. 1069-1074
Aromatic fatty acids such as phenylbutyrate (PB) and its metabolite phenyla
cetate (PA) induce growth arrest, differentiation and apoptosis in solid tu
mor cells. Despite their antiproliferative action they were reported to exh
ibit a synergistic effect in combination with cytotoxic drugs like topoteca
n, and others. Since the activity of the camptothecines (CPTs) depends on l
ocal pH conditions, we investigated, whether PB/PA modulate CPT effects ind
irectly by affecting intracellular pH in SW620 and SW480 colon cancer cells
. The results for the colon carcinoma cells show an antagonistic interactio
n for the combination of CPT and 0.25-5 mM PA in viability assays, resultin
g in an approximately 3-fold increase in IC50 (control: 20 +/-7 nM). A syne
rgistic effect with significantly increased numbers of late apoptotic/necro
tic cancer cells (difference +21 +/-4%) and 1.4-fold sensitization were det
ected upon inclusion of 2.5 mM PA during a 4-h CPT (10 muM) loading phase.
In response to 0.25-1 mM PA/PB the cells exhibit a reversible decrease of p
Hi (0.1-0.31 pH units) in HEPES- or bicarbonate-buffered media. Dose-depend
ent acidification and pHi-recovery occurred following addition of PA and PB
after an acid load and inhibition of the Na+/H+-antiporter and bicarbonate
exchangers, pointing to a possible intracellular mechanism of cytoplasmic
acidification. It is concluded that the synergistic modulation of CPT toxic
ity by short-term PA/PB treatment in colon carcinoma cells is caused by cha
nges in intracellular pH, possibly affecting, quantity and localization of
the active closed lactone form of this drug.